유나이티드 테라퓨틱스 (UTHR)

Apr 22, 2026

United Therapeutics CEO Rothblatt sells $5.42 million in company stock By Investing.com - Investing.com India

Apr 22, 2026

Apr 22, 2026

United Therapeutics CEO Rothblatt sells $5.42 million in company stock - Investing.com

Apr 22, 2026

Apr 22, 2026

United Therapeutics Bets on Manufactured Organs for Long-Term Growth - citybiz

Apr 22, 2026

Apr 20, 2026

United Therapeutics CEO Rothblatt sells $5.57 million in stock By Investing.com - Investing.com India

Apr 20, 2026

Apr 20, 2026

United Therapeutics CEO Rothblatt sells $5.57 million in stock - Investing.com

Apr 20, 2026

Apr 20, 2026

United Therapeutics to present research data at heart and lung conference - Investing.com

Apr 20, 2026

Apr 20, 2026

11 new studies on lung transplants, PH and xenotransplants head to ISHLT - Stock Titan

Apr 20, 2026

Apr 20, 2026

United Therapeutics Corporation (UTHR) Stock Analysis: A Robust Healthcare Play with a 9.47% Upside - DirectorsTalk Interviews

Apr 20, 2026

Apr 19, 2026

UTHR PE Ratio & Valuation, Is UTHR Overvalued - Intellectia AI

Apr 19, 2026

Apr 17, 2026

United Therapeutics (NASDAQ:UTHR) CFO Sells $5,771,800.00 in Stock - MarketBeat

Apr 17, 2026

Apr 17, 2026

Rothblatt, United Therapeutics CEO, sells $5.48 million in stock - Investing.com

Apr 17, 2026

Apr 17, 2026

Rothblatt, United Therapeutics CEO, sells $5.48 million in stock By Investing.com - Investing.com Canada

Apr 17, 2026

Apr 17, 2026

United Therapeutics (NASDAQ:UTHR) Director Christopher Patusky Sells 1,000 Shares - MarketBeat

Apr 17, 2026

Apr 17, 2026

United Therapeutics (UTHR) director sells 1,000 shares after option exercise - Stock Titan

Apr 17, 2026

Apr 17, 2026

United Therapeutics (UTHR) CEO sells 9,500 shares under 10b5-1 plan - Stock Titan

Apr 17, 2026

Apr 17, 2026

United Therapeutics (UTHR) CFO sells 10,000 shares after option exercise - Stock Titan

Apr 17, 2026

Apr 17, 2026

[144] UNITED THERAPEUTICS Corp SEC Filing - Stock Titan

Apr 17, 2026

Apr 16, 2026

Martine Rothblatt Sells 75 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat

Apr 16, 2026

Apr 16, 2026

Martine Rothblatt Sells 9,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat

Apr 16, 2026

Apr 16, 2026

Paul Mahon Sells 8,300 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat

Apr 16, 2026

Apr 16, 2026

United Therapeutics (UTHR) CEO trades shares under Rule 10b5-1 plan - Stock Titan

Apr 16, 2026

Apr 16, 2026

United Therapeutics (UTHR) EVP & General Counsel sells 8,300 shares after option exercise - Stock Titan

Apr 16, 2026

Apr 14, 2026

UNITED THERAPEUTICS CORPORATION (UTHR) - MSN

Apr 14, 2026

Apr 14, 2026

Rothblatt, United Therapeutics CEO, sells $5.5 million in stock By Investing.com - Investing.com South Africa

Apr 14, 2026

Apr 14, 2026

Rothblatt, United Therapeutics CEO, sells $5.5 million in stock - Investing.com

Apr 14, 2026

Apr 14, 2026

United Therapeutics (UTHR) CEO pre-plans 9,500-share option exercise and sale - Stock Titan

Apr 14, 2026

Apr 14, 2026

CFO of United Therapeutics (UTHR) exercises 10k options, sells 10k shares - Stock Titan

Apr 14, 2026

Apr 14, 2026

Assetmark Inc. Sells 10,952 Shares of United Therapeutics Corporation $UTHR - MarketBeat

Apr 14, 2026

Apr 13, 2026

Rothblatt, United Therapeutics CEO, sells $5.4m in UTHR stock - Investing.com UK

Apr 13, 2026

Apr 13, 2026

Rothblatt, United Therapeutics CEO, sells $5.4m in UTHR stock By Investing.com - Investing.com India

Apr 13, 2026

Apr 12, 2026

United Therapeutics stock surges 32% in 6 months: Here's why - MSN

Apr 12, 2026

Apr 12, 2026

UTHR Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Apr 12, 2026

Apr 11, 2026

United Therapeutics (NASDAQ:UTHR) Stock Rating Upgraded by Raymond James Financial - MarketBeat

Apr 11, 2026

Apr 10, 2026

UNITED THERAPEUTICS (UTHR) CEO sells 9,500 shares after option exercise under 10b5-1 plan - Stock Titan

Apr 10, 2026

Apr 10, 2026

Analyst Ratings Update: United Therapeutics (UTHR) Current Price Target Raised | UTHR Stock News - GuruFocus

Apr 10, 2026

Apr 10, 2026

Rothblatt Martine a of United Therapeutics sells $5.5M in UTHR stock - Investing.com India

Apr 10, 2026

Apr 10, 2026

Raymond James initiates United Therapeutics stock coverage with outperform rating - Investing.com Australia

Apr 10, 2026

Apr 09, 2026

Raymond James initiates United Therapeutics stock coverage with outperform rating By Investing.com - Investing.com South Africa

Apr 09, 2026

Apr 09, 2026

Rothblatt Martine a of United Therapeutics sells $5.5M in UTHR stock By Investing.com - Investing.com South Africa

Apr 09, 2026

Apr 08, 2026

Interstitial Lung Disease Market to Witness Accelerated Growth at a CAGR of 8.7% During the Forecast Period (2026–2036) Due to the Launch of Emerging Therapies | DelveInsight - GlobeNewswire Inc.

Apr 08, 2026

Apr 08, 2026

United Therapeutics’ liver device gets FDA regenerative therapy status - Investing.com

Apr 08, 2026

Apr 08, 2026

Bioengineered liver for acute liver failure gets key FDA designation - Stock Titan

Apr 08, 2026

Apr 07, 2026

James Edgemond Sells 10,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat

Apr 07, 2026

Apr 06, 2026

United Therapeutics (NASDAQ:UTHR) CFO Sells $5,615,000.00 in Stock - MarketBeat

Apr 06, 2026

Apr 06, 2026

United Therapeutics CFO Edgemond sells $5.6m in UTHR stock By Investing.com - Investing.com Australia

Apr 06, 2026

Apr 06, 2026

Rothblatt (United Therapeutics) sells $5.3m in UTHR stock By Investing.com - Investing.com Canada

Apr 06, 2026

Apr 06, 2026

United Therapeutics CFO Edgemond sells $5.6m in UTHR stock - Investing.com

Apr 06, 2026

Apr 06, 2026

Rothblatt (United Therapeutics) sells $5.3m in UTHR stock - Investing.com

Apr 06, 2026

Apr 06, 2026

United Therapeutics rises on positive study for cornerstone drug. Why shares could run even higher - MSN

Apr 06, 2026